Mounjaro Patient Suffers Pancreas Death

A 25-year-old woman from Hull, East Yorkshire, has experienced severe health complications after taking Mounjaro, a popular weight-loss medication. She began using the drug in February of this year and within three months, developed acute pancreatitis. This condition, where the pancreas becomes inflamed, rapidly progressed to pancreatic necrosis, a rare complication where the organ's tissue dies due to insufficient blood supply.

Her consultant firmly attributed the severe pancreatitis to Mounjaro, noting the patient's multiple hospital admissions between May and August due to the condition. The patient described excruciating pain, vomiting, and exhaustion, losing two stone while hospitalized. She now faces a permanent risk of recurrent pancreatitis, impacting her life significantly.

Mounjaro, also known as tirzepatide, is a GLP-1 agonist that mimics a natural hormone to aid weight loss. While hailed for its effectiveness, it has been previously linked to pancreatitis. The manufacturer's information leaflet lists inflamed pancreas as an uncommon side effect and advises caution for those with a history of pancreatitis.